In a recent Select Science Editorial Article, Dr. Peter Betz Wolff, of the Analytical Development department at AGC Biologics, who works to implement and develop a range of cell-based assays to meet specific client needs shares how his team recommend the use of assay-ready cells to provide the ... Read more
In a recent Select Science Editorial Article, Dr. Harald Messer, Gene Therapies Senior Scientist at Novartis, talks about the key considerations and challenges associated with developing biologically relevant cell-based assays that reflect mechanisms of action (MoA) and drug potency that represent ... Read more
Biopharmaceuticals, also known as biologics, have revolutionized the treatment of many human diseases in recent years. Immunologic conditions, diabetes, and some forms of cancer are now routinely treated with biopharmaceuticals. Biologics are large protein-based compounds that are developed from ... Read more
We are delighted to announce that we are traveling back to Boston on May 2-6. For the first time in over 2 years, more than 100 exhibitors will be returning to PEGS Boston, and finally, we all meet face to face again. We are also proud to announce that we will present our newest addition to the ... Read more
